Mycenax Biotech Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 194
Employees
  • Stock Symbol
  • 4726
Stock Symbol
  • Share Price
  • $1.26
  • (As of Friday Closing)

Mycenax Biotech General Information

Description

Mycenax Biotech Inc is a Taiwan based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company's pipeline products include TuNEX(opinercept - lyophilizate), TuNEX(opinercept - solution), LusiNEX (tocilizumab), and Omalizumab.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ROCO
Primary Office
  • Research Zhunan Road
  • 4th Floor, 50-7 Keyan Road
  • Zhunan, Miaoli County 350-53
  • Taiwan
+886 03 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mycenax Biotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.26 $1.24 $0.41 - $2.42 $161M 128M 1.07M

Mycenax Biotech Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 193,627 88,865 79,461 75,886
Revenue 20,667 12,648 7,008 10,452
EBITDA 4,175 (3,527) (6,976) (4,845)
Net Income 22 (7,060) (9,097) (6,179)
Total Assets 55,134 47,011 36,580 44,228
Total Debt 1,902 2,803 934 1,267
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Mycenax Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mycenax Biotech‘s full profile, request access.

Request a free trial

Mycenax Biotech Executive Team (1)

Name Title Board Seat Contact Info
Karen Wen Founder & President
To view Mycenax Biotech’s complete executive team members history, request access »

Mycenax Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial